Clinical trial
Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment in…
NCT00149240 · Ipsen, Industry · Completed
Key facts
| NCT number | NCT00149240 |
|---|---|
| Title | Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment in Patients With Primary Myofascial Pain Syndrome |
| Official title | A Phase II, Multicentre, Randomised, Double-blind, Parallel and Controlled With Placebo Pilot Study to Evaluate the Efficacy and Safety of a Single Dose of Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment, in Patients With Primary Myofascial Syndrome of Cervical and Dorsal… |
| Lead sponsor | Ipsen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myofascial Pain Syndromes |
| Intervention type | Biological |
| Interventions | Botulinum toxin type A |
| Enrollment | 24 |
| Start date | Jan 1, 2005 |
| Primary completion | Feb 2, 2006 |
| Completion | Feb 2, 2006 |
| First posted | Sep 8, 2005 |
| Last update posted | Nov 22, 2019 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: